TGFB1 and neoplasm: The elevated IFP could also upregulate the expression of transforming growth factor-β (TGF-β) in tumor cells, which is a major driver of immune dysfunction through recruiting Treg cells and inhibiting CD8+ and helper T cells (93–95).